Cargando…

Advantages of FBPA PET in evaluating early response of anti-PD-1 immunotherapy in B16F10 melanoma-bearing mice: Comparison to FDG PET

PURPOSE: PET with L-4-borono-2-[(18)F] fluoro-phenylalanine (FBPA) was reported to be useful to differentiate malignant tumors and inflammation. Although immunotherapy with immune checkpoint inhibitors (ICIs) has been applied to cancer treatment recently, FDG PET may not be suitable to determine the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tatsumi, Mitsuaki, Soeda, Fumihiko, Naka, Sadahiro, Kurimoto, Kenta, Ooe, Kazuhiro, Fukui, Hideyuki, Katayama, Daisuke, Watabe, Tadashi, Kato, Hiroki, Tomiyama, Noriyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815495/ https://www.ncbi.nlm.nih.gov/pubmed/36620558 http://dx.doi.org/10.3389/fonc.2022.1026608

Ejemplares similares

(18)F-FBPA PET in Sarcoidosis: Comparison to Inflammation-Related Uptake on FDG PET
por: Watabe, Tadashi, et al.
Publicado: (2020)

Effects of New Bayesian Penalized Likelihood Reconstruction Algorithm on Visualization and Quantification of Upper Abdominal Malignant Tumors in Clinical FDG PET/CT Examinations
por: Tatsumi, Mitsuaki, et al.
Publicado: (2021)

Practical calculation method to estimate the absolute boron concentration in tissues using (18)F-FBPA PET
por: Watabe, Tadashi, et al.
Publicado: (2017)

Comparison of the image-derived radioactivity and blood-sample radioactivity for estimating the clinical indicators of the efficacy of boron neutron capture therapy (BNCT): 4-borono-2-(18)F-fluoro-phenylalanine (FBPA) PET study
por: Isohashi, Kayako, et al.
Publicado: (2016)

FBPA PET in boron neutron capture therapy for cancer: prediction of (10)B concentration in the tumor and normal tissue in a rat xenograft model
por: Hanaoka, Kohei, et al.
Publicado: (2014)

Immuno-PET and Targeted α-Therapy Using Anti–Glypican-1 Antibody Labeled with (89)Zr or (211)At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma
por: Watabe, Tadashi, et al.
Publicado: (2023)

Comparison of Conventional and Radiomic Features between (18)F-FBPA PET/CT and PET/MR
por: Liao, Chien-Yi, et al.
Publicado: (2021)

Evaluation of the total distribution volume of (18)F-FBPA in normal tissues of healthy volunteers by non-compartmental kinetic modeling
por: Romanov, Victor, et al.
Publicado: (2019)

Assessment of Mediastinal Tumors Using SUV(max) and Volumetric Parameters on FDG-PET/CT
por: Morita, Takahiro, et al.
Publicado: (2017)

Evaluation of Integrin α(v)β(3) Expression in Murine Xenograft Models: [(68)Ga]Ga-DOTA-C(RGDfK) PET Study with Immunohistochemical Confirmation
por: Mitsuyuki, Kosuke, et al.
Publicado: (2021)

Exploration of the threshold SUV for diagnosis of malignancy using (18)F-FBPA PET/CT
por: Isohashi, Kayako, et al.
Publicado: (2022)

Activated fibroblasts in muscle sarcoidosis revealed by [(18)F]FAPI-74 PET
por: Watabe, Tadashi, et al.
Publicado: (2023)

Automated [(18)F]PSMA-1007 production by a single use cassette-type synthesizer for clinical examination
por: Naka, Sadahiro, et al.
Publicado: (2020)

Evaluation of the default-mode network by quantitative (15)O-PET: comparative study between cerebral blood flow and oxygen consumption
por: Aoe, Jo, et al.
Publicado: (2018)

High detection rate in [(18)F]PSMA-1007 PET: interim results focusing on biochemical recurrence in prostate cancer patients
por: Watabe, Tadashi, et al.
Publicado: (2021)

One-pot and one-step automated radio-synthesis of [(18)F]AlF-FAPI-74 using a multi purpose synthesizer: a proof-of-concept experiment
por: Naka, Sadahiro, et al.
Publicado: (2021)

Duodenal Adenocarcinoma Mimicking Metastasis of Prostate Cancer on (18)F–Prostate-Specific Membrane Antigen–1007 PET/CT
por: Soeda, Fumihiko, et al.
Publicado: (2021)

Initial Evaluation of [(18)F]FAPI-74 PET for Various Histopathologically Confirmed Cancers and Benign Lesions
por: Watabe, Tadashi, et al.
Publicado: (2023)

FDG-PET and PET/CT - Part II
por: Takalkar, Amol M, et al.
Publicado: (2008)

Optimization of [(11)C]methionine PET study: appropriate scan timing and effect of plasma amino acid concentrations on the SUV
por: Isohashi, Kayako, et al.
Publicado: (2013)

Oxygen-15 labeled CO(2), O(2), and CO PET in small animals: evaluation using a 3D-mode microPET scanner and impact of reconstruction algorithms
por: Horitsugi, Genki, et al.
Publicado: (2017)

FDG-PET in lymphoma
por: Meignan, Michel
Publicado: (2014)

PET-FDG: Impetus
por: Nanni, Cristina
Publicado: (2020)

Tumor response evaluation in patients with malignant melanoma undergoing immune checkpoint inhibitor therapy and prognosis prediction using (18)F-FDG PET/CT: multicenter study for comparison of EORTC, PERCIST, and imPERCIST
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Distribution of Intravenously Administered Acetylcholinesterase Inhibitor and Acetylcholinesterase Activity in the Adrenal Gland: (11)C-Donepezil PET Study in the Normal Rat
por: Watabe, Tadashi, et al.
Publicado: (2014)

Prognostic Value of FDG-PET, Based on the Revised Response Criteria, in Patients with Malignant Lymphoma: A Comparison with CT/MRI Evaluations, Based on the International Working Group/Cotswolds Meeting Criteria
por: Isohashi, Kayako, et al.
Publicado: (2015)

Efficacy of FDG-PET for defining gross tumor volume of head and neck cancer
por: Kajitani, Chikae, et al.
Publicado: (2013)

FDG PET or PET/CT in Evaluation of Renal Angiomyolipoma
por: Lin, Chun-Yi, et al.
Publicado: (2013)

FDG-PET in colorectal cancer
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2006)

FDG-PET of Takayasu’s Arteritis
por: Shikino, Kiyoshi, et al.
Publicado: (2014)

FDG-PET/CT in lymphoma
por: D'souza, Maria M, et al.
Publicado: (2013)

FDG-PET and colon cancer
por: Miles, Ken
Publicado: (2015)

Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
por: Enomoto, Keisuke, et al.
Publicado: (2008)

Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
por: Enomoto, Keisuke, et al.
Publicado: (2009)

Reply to: FDG PET and PET/CT: EANM procedure guideline for tumour PET imaging
por: Boellaard, Ronald, et al.
Publicado: (2010)

Detection of primary sites in unknown primary tumors using FDG-PET or FDG-PET/CT
por: Park, Jong Sun, et al.
Publicado: (2011)

Improved Stability and Practicality for Synthesis of 4-Borono-2-[(18)F]fluoro-l-phenylalanine by Combination of [(18)O]O(2) Single-Use and [(18)F]CH(3)COOF Labeling Agents
por: Naka, Sadahiro, et al.
Publicado: (2022)

Potential advantages of FDG‐PET radiomic feature map for target volume delineation in lung cancer radiotherapy
por: Falahatpour, Zahra, et al.
Publicado: (2022)

Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer
por: Al-Ibraheem, Akram, et al.
Publicado: (2009)

FDG-PET Versus PSMA-PET: A Patient With Prostate Cancer
por: Kichloo, Asim, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_970tl39lt6cvijcik13g7osdmc